MedPath

Danube Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure

Phase 1
Completed
Conditions
Ocular Hypertension
Elevated IOP
Glaucoma
Interventions
First Posted Date
2008-05-23
Last Posted Date
2009-06-03
Lead Sponsor
Danube Pharmaceuticals, Inc.
Target Recruit Count
54
Registration Number
NCT00683501
Locations
🇬🇧

Omnicare Clinical Research Center, Chippenham, Wiltshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath